: HEMATOLOGY ffi
Transcript of : HEMATOLOGY ffi
FINAL EXAMDECEMBER 2O1T
: HEMATOLOGYffiPAPER- I
Time : 3 hoursMax. Marks : 100
Attempt all questions in order.Each question carries 10 marks.
Write short notes on:-
NATIONAL BOARD OF EXAMINATIONS
HEMAT'DI11I48II
1 .
2 .
3.
4.
5.
6.
7,
8.
9.
10 .
Recent concepts of iron absorption.
Hemophilia carrier detection.
FISH in hematology.
Inherited bone marrow failure syndromes.
Detection of Minimal Residual Disease.
Diagnosis of PNH and its relevance to management.
Hematological manifestations of Parvo virus B g infection.
Alpha-thalassemia in India.
ChiHhood myelodysplastic synd rome.
Rote of flow cytometry in chronic lymphoproliferative disorders.
* * * * *
POSSESSION/ASE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDETHE H(AMINATION HALL
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
FINAL EXAMDECEMBER 2011
NATIONAL BOARD OF EXAMINATIONS
HEMATOLOGY-
PAPER- II
HEMAT/DI11I48III
1 0
1 0
1 0
1 .
2.
3.
Time :3 hoursMax. Marks : 100
Attempt all questions in order.Each question carries 10 marks.
Write short notes on:-
Advances in the management of multiple myeloma.
Management of Sickle Cell Disease.
lmmunological abnormalities in chronic lymphocytic leukemiaand their management.
How would you investigate and manage a case of drug inducedhemolytic anemia?
Newer chelating agents.
Managementofdif fuse|argece|lB.ce|| |ymphoma
Indications of bone marrow transplantation in AML.
Targeted therapy in hematological malignancies.
Diagnosis and management of Sq-syndrome.
Management of steroid refractory lTP.
* * : F * *
POSSESSIONIUSE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PEBMITTED INSIDETHE EruMINATION HALL
4.
5.
6.
7.
8.
9.
10 .
1 0
1 0
1 0
1 0
1 0
1 0
1 0
FINAL EXAII,IDECEMBER 2OI1
Time : 3 hours
Attempt all questions in order.Each question carries 10 marks.
' NATIONAL BOARD OF EXAMINATIONS
HEMATOLOGY%
PAPER.II I
HEMATIDIllI4SIIII
1 .
2 .
3.
4.
5.
6.
7.
8.
9.
10 .
Discuss the hematological manifestations of Hlv infection.
GVHD in blood transfusions.
Recombinant coagulation factors and their uses.
Procurement and preservatioh of stem celts.
Inhibitors of fibrinolytic system.
Hemophagocytic syndromes.
Free light chain assay.
Variants of Hairy Cell Leukemia.
Coagulation abnormalities in liver disease.
G:6-PD deficiency,
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
1 0
* t * * *
POSSESSION/ASE OF CELL PHONES OR ANY SACH ELECTRONIC GADGETS IS NOT PENMITTED INSIDETHE HAMINATION HAL,L